Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care

Ischemic heart disease (IHD) is the leading global cause of death and is assumed to entail a significant social and economic burden globally. This study aimed to evaluate incidence and mortality trends of IHD in Spain and to estimate direct medical costs (...)

Detalles Bibliográficos
Autores: Darbà, Josep, Marsà, Alícia
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2022
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/190125
Acceso en línea:https://hdl.handle.net/2445/190125
Access Level:acceso abierto
Palabra clave:Política sanitària
Cost de l'assistència sanitària
Mortalitat
Isquèmia
Malalties cardiovasculars
Medical policy
Cost of medical care
Mortality
Ischemia
Cardiovascular diseases
id ES_5c1910dd81cb89fa2e7a9355cd41eb26
oai_identifier_str oai:diposit.ub.edu:2445/190125
network_acronym_str ES
network_name_str España
repository_id_str
spelling Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital careDarbà, JosepMarsà, AlíciaPolítica sanitàriaCost de l'assistència sanitàriaMortalitatIsquèmiaMalalties cardiovascularsMedical policyCost of medical careMortalityIschemiaCardiovascular diseasesIschemic heart disease (IHD) is the leading global cause of death and is assumed to entail a significant social and economic burden globally. This study aimed to evaluate incidence and mortality trends of IHD in Spain and to estimate direct medical costs (...)Informa Healthcare2022info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfhttps://hdl.handle.net/2445/190125Articles publicats en revistes (Economia)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésVersió postprint del document publicat a: https://doi.org/10.1080/14737167.2022.2108794Expert Review of Pharmacoeconomics & Outcomes Research, 2022, vol. 22, num. 7, p. 1147-1152https://doi.org/10.1080/14737167.2022.2108794(c) Informa Healthcare, 2022info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1901252026-05-27T06:46:51Z
dc.title.none.fl_str_mv Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care
title Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care
spellingShingle Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care
Darbà, Josep
Política sanitària
Cost de l'assistència sanitària
Mortalitat
Isquèmia
Malalties cardiovasculars
Medical policy
Cost of medical care
Mortality
Ischemia
Cardiovascular diseases
title_short Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care
title_full Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care
title_fullStr Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care
title_full_unstemmed Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care
title_sort Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care
dc.creator.none.fl_str_mv Darbà, Josep
Marsà, Alícia
author Darbà, Josep
author_facet Darbà, Josep
Marsà, Alícia
author_role author
author2 Marsà, Alícia
author2_role author
dc.subject.none.fl_str_mv Política sanitària
Cost de l'assistència sanitària
Mortalitat
Isquèmia
Malalties cardiovasculars
Medical policy
Cost of medical care
Mortality
Ischemia
Cardiovascular diseases
topic Política sanitària
Cost de l'assistència sanitària
Mortalitat
Isquèmia
Malalties cardiovasculars
Medical policy
Cost of medical care
Mortality
Ischemia
Cardiovascular diseases
description Ischemic heart disease (IHD) is the leading global cause of death and is assumed to entail a significant social and economic burden globally. This study aimed to evaluate incidence and mortality trends of IHD in Spain and to estimate direct medical costs (...)
publishDate 2022
dc.date.none.fl_str_mv 2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/190125
url https://hdl.handle.net/2445/190125
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2022.2108794
Expert Review of Pharmacoeconomics & Outcomes Research, 2022, vol. 22, num. 7, p. 1147-1152
https://doi.org/10.1080/14737167.2022.2108794
dc.rights.none.fl_str_mv (c) Informa Healthcare, 2022
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) Informa Healthcare, 2022
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Informa Healthcare
publisher.none.fl_str_mv Informa Healthcare
dc.source.none.fl_str_mv Articles publicats en revistes (Economia)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869408865302347776
score 15,301629

Similares en LA Referencia